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Abstract
Background: Exact analysis of equine insulin in blood samples is the key element for assessing insulin resistance
or insulin dysregulation in horses. However, previous studies indicated marked differences in insulin concentrations
obtained from sample analyses with different immunoassays. Most assays used in veterinary medicine are originally
designed for use in human diagnostics and are based on antibodies directed against human insulin, although
amino acid sequences between equine and human insulin differ. Species-specific assays are being used more
frequently and seem to provide advantages compared to human-specific assays. The aim of this study was to
compare three immunoassays, one porcine-specific insulin enzyme-linked immunosorbent assay (ELISA), advertised
to be specific for equine insulin, one porcine-specific insulin radioimmunoassay (RIA) and one human-specific insulin
chemiluminescence immunoassay (CLIA), all three widely used in veterinary laboratories for the analysis of equine
insulin. Furthermore, we tested their clinical applicability in assessing insulin resistance and dysregulation by analysis
of basal blood and blood samples obtained during a dynamic diagnostic stimulation test (OGT) with elevated insulin
concentrations.
Results: Insulin values obtained from the ELISA, RIA and CLIA, investigated for analyses of basal blood samples differed
significantly between all three assays. Analyses of samples obtained during dynamic diagnostic stimulation testing with
consecutively higher insulin concentrations revealed significantly (p < 0.001) lower insulin concentrations supplied by
the CLIA compared to the ELISA. However, values measured by ELISA were intermediate and not different to those
measured by RIA. Calculated recovery upon dilution, as a marker for assay accuracy in diluted samples, was 98 ± 4 %
for ELISA, 160 ± 41 % for RIA and 101 ± 11 % for CLIA.
Conclusions: Our results indicate that insulin concentrations of one sample measured by different methods vary
greatly and should be interpreted carefully. Consideration of the immunoassay method and reliable assay-specific
reference ranges are of particular importance especially in clinical cases where small changes in insulin levels can
cause false classification in terms of insulin sensitivity of horses and ponies.
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Background
The equine metabolic syndrome (EMS) has attracted
increasing attention in equine veterinary practice in
recent years and is becoming more common due to
today’s horse husbandry and feeding practices. Different
diagnostic tests to determine dysregulation of glucose
and insulin homeostasis in horses are currently used to
diagnose EMS. Tests are based on quantitative measures
either of basal serum insulin concentration in fasted and
non-fasted horses or of increased insulin concentration
stimulated by oral [1, 2] or intravenous [3] dynamic
diagnostic tests. Complex hyperinsulinaemic euglycae-
mic clamp (HEC) tests, which were considered to be
the gold standard for assessment of insulin resistance
(IR) [4], were usually reserved to research approaches
due to their complex and expensive implementation.
High insulin indicative of IR or insulin dysregulation (ID)
in EMS horses is one of the features associated with this
metabolic disorder [5]. Exact pathophysiology resulting in
IR is not known to date. Several hypothesis leading to the
clinical signs have been discussed in literature. Increased
insulin degradation or neutralization, decreased binding of
insulin to its receptor, as well as impaired downstream
signaling were described. Whereas the term IR used in
context with EMS is mainly characterized by reduced
tissue response of insulin-dependent tissues the newly
introduced term ID is used to describe in summary
abnormalities of insulin metabolism [5]. Therefore, an
exact quantification of insulin by laboratory analysis is
the most important and challenging step to diagnose
EMS-related changes in insulin regulation. Several im-
munoassay methods for the quantification of insulin in
equine serum or plasma samples are commercially avail-
able. However, due to the use of different methods for
quantifying equine insulin, discrepancies between results
obtained from different studies have occurred [6, 7]. Since
no assay with a specific antibody against equine insulin
is available, most of the commercial immunoassays are
based on antibodies directed against human or non-
equine insulin. Only one enzyme-linked immunosorb-
ent assay (ELISA) advertised by the manufacturer as
being specific for measuring equine insulin is commer-
cially available1, and this is based on anti-porcine insu-
lin antibodies. This assay has been validated for use in
horses [8] and has already been used successfully in
several studies [9, 10].
The aim of our study was to compare the results of
this equine-optimized porcine-specific ELISA with re-
sults obtained from a radioimmunoassay2 (RIA) and a
chemiluminescence immunoassay3 (CLIA) for measure-
ments of equine insulin in serum samples. Further-
more, the second aim of the study was to evaluate the
applicability of the three assays for samples obtained
from horses and ponies under fasted conditions and
from horses and ponies with stimulated insulin secre-
tion during diagnostic procedure.
Methods
Animals and samples
Forty blood serum samples were collected from seventeen
horses and ponies of different breeds, age (14 ± 6 years),
weight (478 ± 179 kg) and body condition score (6.8 ± 1.1)
to obtain samples with a broad range of insulin concen-
trations. Blood samples from healthy, university-owned
horses were collected during a study, which has been
approved by the ethics committee within the University
of Veterinary Medicine, Hannover, and the State Office
for Consumer Protection and Food Safety in accord-
ance with the German Animal Welfare Law (LAVES–
Reference number: 33.14 42502-04-13/1259). Blood sam-
ples from insulin dysregulated horses and ponies were col-
lected during routine diagnostic procedures in the Clinic
for Horses and informed consent was obtained from the
clients for publication. Blood samples were collected after
fasting the horses overnight (basal, n = 20), and addition-
ally after stimulation by an oral glucose testing (OGT,
n = 20) procedure [2]. OGT was carried out by adminis-
tering 1 g/kg btw glucose powder dissolved in two liters
water by naso-gastrical-tubation. Samples were collected
via jugular vein catheter, transferred into plain tubes4
for serum preparation and were incubated at room
temperature for 1 h, centrifuged at 3000 g for 6 min
and serum was stored at −80 °C. Prior to analyses sam-
ples were thawed once and split into different aliquots
containing the required volume for each assay. After-
wards, they were re-frozen and sent on dry ice to the
laboratories.
Assays
The porcine-specific insulin assay1 is a solid phase two-
side sandwich ELISA optimized for the quantification of
equine insulin in serum or plasma. It is based on mono-
clonal mouse anti-porcine insulin antibodies coupled to
plate and free monoclonal mouse anti-porcine insulin
antibody conjugate labeled with horseradish peroxidase.
Porcine insulin is used for calibrators to compute cali-
bration curve via cubic spline regression. The limit of
detection for this assay is 1.17 μIU/mL, but concentra-
tions of samples with absorbance below the lowest cali-
brator (2.34 μIU/mL) should not be calculated. Cross
reactivity of the assay is stated at 100 % for porcine insulin
and 22 % with human insulin (according to the manufac-
turer’s protocol) (Table 1).
For sample analysis by RIA, a porcine-specific one-site
insulin RIA2 was used. This assay is based on 125I-labeled
insulin and used guinea pig anti-porcine insulin antibodies
and goat anti-guinea pig IgG antibodies. Purified human
recombinant insulin preparations were used as standards
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for calibration. The manufacturer’s protocol referred to
the assay’s limit of linearity of 200 μIU/mL and recom-
mended diluting the samples which have greater con-
centrations with the assay buffer. The limit of detection
for this assay is 1.61 μIU/mL when 100 μl of sample is
used. The cross-reactivity of the assay is stated at 100 %
for porcine insulin, 100 % for human insulin and 90 % for
bovine insulin. No information about cross-reactivity for
equine insulin is given by the manufacturer. Measure-
ments with the RIA were performed by a commercial
veterinary endocrinology laboratory.
A human-specific insulin chemiluminescent immuno-
assay4 with two-site sandwich technique and direct chemi-
luminescent technology was used for the sample analysis
by CLIA. The assay is based on monoclonal mouse anti-
insulin antibodies and chemiluminescent detection with
monoclonal mouse anti-insulin antibodies labeled with
acridinium ester. The limit of detection of this assay is
0.5 μIU/mL and the measuring range is from 1.0 to 300
μIU/mL. No information about cross-reactivity for equine
insulin is given by the manufacturer. Measurements using
the CLIA were performed by a commercial veterinary
laboratory. Due to the fact that all tested assays use no
equine standards, all the assays only provide an approxi-
mation of equine insulin concentrations.
Revalidation of the equine-optimized porcine-specific
insulin ELISA
Intra-assay CV was calculated by division of the stand-
ard deviation by the corresponding mean of 15 replicates
of equine serum samples with low (mean: 2.34 μIU/mL)
and medium (mean: 108.81 μIU/mL) insulin concentra-
tions. Inter-assay CV was calculated by division of the
standard deviation by the corresponding mean of replicate
samples, each measured on 25 different plates. Commer-
cial controls5 with low (5.03 μIU/mL), medium (18.84
μIU/mL) and high (60.84 μIU/mL) insulin concentrations
(classifications according to manufacturer), and equine
serum samples with low (mean: 10.53 μIU/mL) and
medium (mean: 109.98 μIU/mL) insulin concentrations
were used for the calculation of concentration-dependent
inter-assay CVs. The recovery upon dilution (RUD) and
the linearity of dilution were calculated to prove accuracy.
A sample selected with a medium insulin concentration
(99.45 μIU/mL) was measurable without any dilution and
in five different dilution steps up to the 1:40 ratio dilution
within the calibration range of the assay. Sample buffer6
was used for dilution and at least 40 μl of the equine
serum sample.
Comparison of methods
Basal serum samples and simulated samples from the
OGT procedure were measured undiluted in all three
assays for comparison of methods. Moreover, stimulated
samples were additionally measured diluted in a ratio of
1:4 with sample buffer6 to calculate the RUD for each
assay to prove accuracy in the measurement of dilution
procedure. The RUD was calculated as a percentage re-
covery of the insulin concentration in the diluted sample
related to the corresponding undiluted samples. The RUD
analyses were performed without the knowledge of the
laboratories commissioned.
Stability of insulin after freezing, thawing and eight
weeks of storage
In order to investigate the effect of repeated freezing and
thawing on the stability of insulin in serum samples
measured by equine-optimized, porcine-specific ELISA,
33 samples were thawed, measured and refrozen at
−80 °C. Eight weeks later, samples were thawed at am-
bient temperature for 1 h and measured again. Samples
covering a broad range of insulin concentrations were
chosen to match the assay’s analytical range from 2.34
to 175.5 μIU/mL. The samples were subdivided into three
subgroups of low (3.51–15.21 μIU/mL), medium (30.42–
90.09 μIU/mL) and high (92.43–125.19 μIU/mL) concen-
trations with eleven samples in each subgroup.
Statistics and calculations
Data analysis was performed using GraphPad Prism soft-
ware7. The Shapiro-Wilk normality test was used to assess
the normality of data distribution. Wilcoxon matched-
pairs signed rank test, Spearman correlation and Deming
regression analyses were used to compare results from dif-
ferent assays and to verify relationships between the three
methods. In cases of assay-based non-detectable insulin
concentrations, the corresponding samples were excluded
from the statistics. Bland-Altman analysis was performed
to calculate method-dependent bias and limits of agree-
ments. Wilcoxon matched-pairs signed rank test was also
Table 1 Information about the three assays examined for quantification of equine insulin
Assay Standards Primary antibody Second antibody
Mercodia Equine Insulin ELISA Porcine insulin Mouse monoclonal anti-porcine insulin Mouse monoclonal anti-porcine insulin
HRP-conjugate
Millipore Porcine Insulin RIA Human recombinant insulin Guinea pig anti-porcine insulin Goat anti-guinea pig IgG
Siemens ADVIA Centaur Insulin
Assay
-a Monoclonal mouse anti-insulin AE-conjugate Monoclonal mouse anti-insulin coupled
to paramagnetic particles
aNo information available
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used to examine the effect of repeated freezing and
thawing on the stability of equine insulin. Statistical sig-
nificance was set at p < 0.05.
Results
In re-validation experiments, intra-assay CV was 4.61 %
at low insulin concentrations (2.34 μIU/mL) and 1.91 % at
medium insulin concentrations (108.81 μIU/mL) using
the equine-specific insulin ELISA. The inter-assay CV
was 5.27 %, 3.24 % and 3.17 % for the low (reference
value 5.03 μIU/mL insulin), medium (reference value
18.84 μIU/mL insulin) and high (reference value 60.84
μIU/mL insulin) commercial controls, respectively. Inter-
assay CVs for equine serum samples were 7.34 % and
4.83 % for low (mean: 10.53 μIU/mL) and high concentra-
tions (mean: 109.98 μIU/mL), respectively. The RUD in
the first revalidation experiment was 95 % (range from 94
to 96 %), calculated in five dilution steps. The linearity
upon dilution was excellent (r2 = 0.9994; p < 0.0001),
showing a strong relationship between the calculated
and measured concentrations of the diluted samples
(Fig. 1).
The ELISA provided results within the analytical range
for 17 of 20 basal samples and for 11 of 20 stimulated
samples (Table 2). The analytical range of the assay was
from 2.34 to 175.5 μIU/mL (corresponding range in
μg/L: 0.02 to 1.5; conversion factor: 117), as stated by
the manufacturer. The mean RUD in samples analyzed
by ELISA was 98 ± 4 % (Fig. 2a).
The RIA supplied results for 19 basal samples and for
all 20 stimulated samples (Table 2). The analytical range
for the RIA was stated as 1.61 to 200.00 μIU/mL. The
RUD in the RIA analyses was 160 ± 41 % (Fig. 2b).
One of the stimulated samples from the OGT proced-
ure was not measureable within the analytical range
(1.0 to 300 μIU/mL) in the CLIA (reported as > 300
μIU/mL) (Table 2). The RUD in the CLIA analyses was
101 ± 11 % (Fig. 2c).
A comparison of the results provided by the three
methods of analysis of basal, fasted blood samples for
equine insulin indicated statistically significant differences
(Fig. 3). Results provided by the CLIA for basal blood
samples were significantly (p < 0.001) lower compared to
results supplied by ELISA or RIA (Fig. 3b, c). Further-
more, differences between ELISA and CLIA in stimulated
samples were statistically significant (Fig. 4b), whereas
results supplied by ELISA and RIA and RIA and CLIA
did not differ significantly (Fig. 4a, c). Despite these dif-
ferences between insulin concentrations measured by
ELISA, RIA and CLIA, Spearman correlations and Deming
regression analyses revealed significant correlations and
linear relations between all three assays tested (Fig. 5a–c).
Bland-Altman Plot analyses showed good agreement with
a small bias of −0.44 μIU/mL (95 % limits of agreement:
−18.12 to 18.99) comparing the results of ELISA and RIA
(Fig. 6a), whereas variations in the results supplied by
ELISA compared to CLIA (Fig. 6b; bias: 17.65 μIU/mL;
95 % limits of agreement: −13.92 to 49.22) and CLIA to
RIA (Fig. 6c; bias: −8.39 μIU/mL; 95 % limits of agreement:
−56.76 to 39.98) occurred. Additionally, the range of
variation between results from ELISA and CLIA and
between CLIA and RIA increased with elevated insulin
concentrations (Fig. 6b, c).
The average recovery rate of equine insulin in 33 samples
after one cycle of refreezing and thawing was 97 ± 17 %,
but the corresponding range of recovery stretched from
71 to 158 %. In total, insulin concentrations were signifi-
cantly (p = 0.0232) lower in the second measurement
(54.99 ± 40.95 μIU/mL) compared to the first (58.5 ± 43.29
μIU/mL). When samples were subdivided into concentra-
tion range groups of low (3.51–15.21 μIU/mL), medium
(30.42–90.09 μIU/mL) and high (92.43–125.19 μIU/mL)
concentrations, the range as well as the mean recovery be-
tween the three concentration ranges differed, but there
was no statistically significant difference between the first
and second measurement when samples were clustered
in subgroups depending on concentration. The mean
Fig. 1 Linearity upon dilution in porcine-specific insulin ELISA. Linear
regression analysis indicates best-fit line of Y = 0.9987 x – 0.7385
(r2 = 0.9994, P = < 0.0001)
Table 2 Information about the number of samples which were
measureable within the analytical ranges of the three assays
investigated, without previously dilution
Assay Number of samples
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recovery was 98 ± 16 % (range: 79 to 129 %) in the
low, 99 ± 24 % (range: 74 to 158 %) in the medium
and 92 ± 12 % (range: 71 to 107 %) in the high con-
centration group.
Discussion
Most immunoassays used in veterinary medicine for ana-
lyzing insulin concentrations in equine serum or plasma
samples were originally designed for human diagnostics
and research, and specific immunoassays for the quantifi-
cation of equine insulin are not commercially available. A
human-specific insulin radioimmunoassay8 was used in
a variety of equine studies [3, 11, 12] in which several
IR and ID diagnostic tests and related reference ranges
for plasma and serum insulin had been established.
Unfortunately, this assay is no longer available, thus,
there is an urgent need to reevaluate the reference ranges
established on analyses from samples measured with other
approaches for measuring insulin.
Reproducibility, recovery upon dilution and measuring
range of assays
The CVs calculated for the ELISA showed that insulin
concentration-dependent differences in CVs occurred and
that the CVs calculated by the use of equine serum sam-
ples were higher than the CVs stated in the manufacturer’s
protocol. Very high or low insulin concentrations could
not be detected by all assays due to the various analytical
ranges of the assays. Therefore, as samples vary greatly in
insulin concentration when obtained in fasted conditions
or in dynamic diagnostic tests with induced insulin secre-
tion, selection of an assay with an appropriate analytical
range is important for the detection of very high or low
insulin concentrations. Moreover, our results show that
samples with high insulin concentrations, similar to those
that can occur in patients with IR or ID, needed to be di-
luted in some cases to obtain results. Although the ELISA
offered the smallest analytical range of the three assays
tested, its excellent RUD results enabled the coverage of a
broad range of insulin concentrations. Using this ELISA
allowed valid measurements of earlier diluted samples of
dynamic diagnostic tests. By contrast, using the RIA, all
samples could be measured without dilution in the analyt-
ical range of the assay. However, RUD experiments did
not provide satisfactory results. In a substantial amount of
samples, too high insulin concentrations were obtained
for the diluted samples compared to the corresponding
undiluted samples. The CLIA offered the widest analytical
Fig. 2 Recovery upon dilution (RUD) of equine insulin in the three assays investigated: a ELISA (98 ± 4 %), b RIA (160 ± 41 %) and c CLIA (101 ± 11 %).
The RUD was calculated as percentage recovery of the insulin concentration in the 1:4 diluted sample related to the corresponding undiluted sample.
Samples were diluted with commercially available sample buffer6
Fig. 3 Insulin concentrations measured in basal, fasted blood samples by ELISA, RIA and CLIA. Data were analyzed by Wilcoxon matched-pairs
rank test. a ELISA and RIA (n = 17) b ELISA and CLIA (n =1 7) c RIA and CLIA (n = 20). *p < 0.05, **p < 0.01, ***p < 0.001
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range when compared to the other two assays, but also
could not measure all high insulin concentration samples.
This assay, similar to the ELISA, exhibited good RUD
results, leading to the conclusion that appropriate dilution
of samples in this assay do not falsify results.
Dilution buffers
We used commercially available sample buffer6 to dilute
the samples in this study. This buffer was designed for
use in the ELISA investigated. Öberg and colleagues [8]
evaluated the RUD and linearity of dilution in this
ELISA with physiologic saline as a dilution medium in
four dilution steps and found similar results regarding
linearity, but poorer RUD of 92 to 122 %. Dilution of
serum samples with zero calibrator provided in the
ELISA yielded higher recovery rates of 102.4 ± 20.5 % in
another study [13]. Therefore, dilution of samples with
the manufacturer’s commercially available sample buffer6
seems to improve results obtained from diluted samples
in this assay. Tinworth and colleagues [6] recommended
that samples with high insulin concentrations which re-
quired dilution should be diluted with charcoal stripped
equine plasma instead of the manufacturer’s diluent in
order to improve results obtained by analysis with a hu-
man-specific insulin RIA8 mentioned previously. One
limitation in our study is that all our samples have been di-
luted with commercially available sample buffer6 designed
for use in the equine-optimized, porcine-specific ELISA
and were then used in the different assays. Therefore,
results of this RUD analysis may also be impaired by in-
teractions of the dilution medium and assay compo-
nents. The RUD results may be improved by using an
appropriate method-dependent dilution medium.
Insulin molecule stability
The stability of insulin in blood samples is a commonly
discussed issue in both human and veterinary medicine.
Optimal pre-analytical handling of samples is essential
for valid analytical results, but is often not feasible in the
daily routine of an ambulatory practice. The recovery
range observed indicates quite variable results. Some of
the refrozen and thawed samples measured had a lower
insulin concentration in the second analysis, whereas
others had higher insulin concentrations. Parts of the
variations and effects between the first and second
measurement may be due to inter-assay variations, but,
as already presented, inter-assay CVs for low equine in-
sulin concentration samples and high insulin concen-
tration samples in the ELISA were within the generally
accepted variation range for immunoassays [14]. A study
Fig. 4 Insulin concentrations measured in stimulated blood samples from OGT procedure by ELISA, RIA and CLIA. Data were analyzed by
Wilcoxon matched-pairs rank test. a ELISA and RIA (n = 11) b ELISA and CLIA (n = 11) c RIA and CLIA (n = 19). *p < 0.05, **p < 0.01, ***p < 0.001
Fig. 5 Scatterplot of measurement results for basal and stimulated samples ELISA compared to a RIA and b CLIA. c Scatterplot of results supplied
by CLIA compared to RIA
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by Livesey and colleagues [15] indicated that repeated
thawing and freezing affected the insulin concentration
in human plasma samples collected during intravenous
glucose tolerance testing procedures. Insulin concentra-
tions had already declined after the first freezing and
thawing cycle and exhibited a continuous decline during
following freezing and thawing cycles. A more recent
study by Mechanic and colleagues [16] examined the ef-
fect of short-term refrigerated storage at ≤ −70 °C on insu-
lin in human blood samples and found no significant
effect in a time period of 72 h and also no significant effect
of delays in freezing following centrifugation 2 h post-
collection, whereas they observed declined insulin concen-
trations following delays in centrifugation. Furthermore,
repeated freezing and thawing of serum did not affect the
concentrations of insulin in serum samples from beagle
dogs [17]. Borer-Weier and colleagues [13] evaluated the
stability of equine insulin after freezing and thawing in
their study and showed similar results to our study, with
large ranges of differences in the samples analyzed with
human-specific RIA8 and a high-range porcine insulin
ELISA. One limitation in our study design, as well as in
other previous studies, was that serum insulin concentra-
tions were not measured directly after the sampling pro-
cedure, prior to first freezing, so the effect of the first,
initial freeze remains unknown. Taking into account the
variable effects of freezing and thawing on the insulin con-
centrations in the samples we analyzed, we recommend
that samples are not frozen and thawed any more than
necessary in order not to receive false results.
Conversion factors for insulin measures
Various conversion factors have been established in the
past due to the differences in insulin binding efficacy.
Data had to be converted from μg/L into the commonly
used SI unit μIU/mL to compare the results from ELISA
with results derived from RIA and CLIA. In previous
studies in which insulin analysis had been performed
with the equine-optimized porcine-specific ELISA, data
was either presented in μg/L [9, 10, 18] or converted into
mU/L [19]. In the latter case, conversion was performed
without an exact statement regarding the conversion
factor, which was suggested to be 10 in an earlier publica-
tion by the same author [9]. In addition, the factor 28.69
(1 μg/L = 28.69 for μIU/mL) [20] for the conversion of
human insulin was discussed. However, for the ELISA
used in our study, the cross-reactivity with the human
insulin molecule is only 22 %, as declared by the manu-
facturer. Therefore, the use of both factors for conver-
sion of the data generated by the equine-optimized,
porcine-specific ELISA might be questionable. Thus,
another equine-specific conversion factor (1 μg/L =
117 mU/L) was given by the manufacturer for this assay
[21] and was used for the calculation of data in our study.
Comparison of methods and assay insulin antibodies
Equine insulin has a lower molecular weight (5.748 kDa)
compared to human (5.808 kDa) and porcine insulin
(5.778 kDa) and consists of 51 amino acids. The equine
insulin differs from the human and porcine insulin mol-
ecule in the amino acid sequence [22, 23]. Even slight
differences in the amino acid sequences between species
and, thus, secondary structure can result in impaired
antibody binding and can, therefore, cause variations in
efficacy when measuring insulin by different immunoassay-
based methods. Comparing the results of converted
data, all three methods provided different insulin con-
centrations within the same samples. The CLIA results
observed in this study were markedly lower than the
results supplied by the ELISA and the RIA. Data ana-
lyses with Bland-Altman plots and Deming regression
analyses indicated that there was no constant systemic
error, meaning that one method measures consistently
higher or lower than the other ones. The ELISA sup-
plied higher insulin concentrations than the CLIA and
the difference between both methods even increased
with rising concentrations, indicating the presence of pro-
portional error. The CLIA also provided lower results
than the RIA for samples with concentrations under
100 μIU/mL, but when the concentration exceeded 100
μIU/mL, the CLIA supplied higher results for five sam-
ples compared to the RIA. These differences between
Fig. 6 Bland-Altman plot of average compared to difference a ELISA minus RIA (n = 28), b ELISA minus CLIA (n = 28) and c CLIA minus RIA (n = 39).
Dashed line = bias, pointed line = 95 % limits of agreements
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insulin concentration results provided by the three
assays may be caused by underlying antibodies used in
the different assays. The ELISA and the RIA were based
on antibodies directed against porcine insulin, which
differs in amino acid 9 of the A chain (glycine in equine
insulin and serine in porcine insulin), whereas human
and equine insulin differ in amino acid 9 on the A
chain and amino acid 30 of the B chain (alanine in
equine insulin and threonine in human insulin) [22].
Differences at amino acid 9 on the A chain are not consid-
ered to be important for biological activity, but changes in
amino acid 30 on the B chain were discussed to affect the
3D structure [23, 24]. Therefore, the markedly lower
results provided by the CLIA may be caused by a loss of
homology in this position and variation in 3D structure,
which may impair sufficient antigen-antibody binding by
steric interference. Furthermore, alterations in the anti-
genic epitope for the anti-human insulin antibody used
in the CLIA may cause insufficient antigen-antibody
binding. Variations in insulin concentrations, such as
occurred in our study, have already been described by
several authors for other assays and methods used fre-
quently. Tinworth and colleagues [6] compared the
equine-optimized, porcine-specific insulin ELISA and a
modified version of the human-specific RIA8 in their
investigations. Both assays gave different insulin con-
centration results for the same samples as well, and
underestimated the insulin concentration compared to
liquid chromatography and high-resolution/high-accuracy
mass spectrometry (LC-MS) [6]. The LC-MS provides
absolute amounts of insulin and could be assessed as a
gold standard to measure insulin concentrations in blood
samples. Due to a lack of LC-MS in our study, potential
over- or underestimation of the assays examined could
not be evaluated. Banse and colleagues [7] compared the
human-specific RIA8 with another commercially available
CLIA9 which is often used for the measurement of equine
insulin in both clinical practice and research. Both the
human-specific RIA8 and the CLIA9 resulted in poor re-
covery rates within each assay and showed poor accord-
ance. They, furthermore, examined the recovery of equine
insulin standard within both assays. The recovery rate was
poor in both assays, but the CLIA9 investigated showed
recovery rates of only up to 10 %. However, no equine in-
sulin standard was available in our experiments; therefore,
we could not examine the equine insulin standard recov-
ery in the three immunoassays investigated in this study.
Clinical relevance of valid insulin measures
The clinical relevance of result variation becomes obvious
when focusing on basal samples. According to the current
state in equine veterinary practice, analysis of basal samples
from fasted patients as a screening method for IR and ID
accounts for a large proportion of insulin measurements in
veterinary diagnostics. In veterinary practice, basal insulin
concentrations of 20 μIU/mL were stated as cut-off values
to distinguish between healthy and insulin-resistant or
insulin-dysregulated horses in the consensus statements
of the American College of Veterinary Internal Medicine
[12]. On closer inspection, this cut-off value was sug-
gested as being valid for sample analyses resting upon
the Coat-A-Count insulin radioimmunoassay8 (Siemens
Medical Solutions Diagnostics, Los Angeles, CA), Immu-
lite insulin solid-phase chemiluminescent assay9 (Siemens
Medical Solutions Diagnostics) and DSL-1600 insulin
radioimmunoassay (Diagnostic Systems Laboratory Inc,
Webster, TX) by the authors of the consensus state-
ment. However, this cut-off value is often used without
consideration of the underlying analysis method. Thus,
assay-dependent differences in the insulin concentra-
tion levels measured can cause false classification of
patients. Calculations of indices, which are based on
basal insulin and glucose concentrations for estimation
of IR, were used more commonly [25] and, therefore,
could result in false diagnosis of IR. Exact differenti-
ation between 15 and 30 μIU/mL may be very import-
ant for the interpretation of basal samples. In six of the
seventeen animals investigated, analysis of basal, fasted
blood samples by the three assays investigated led to differ-
ent classification as insulin-sensitive or insulin-dysregulated
depending on the data used. One of our samples illustrates
this problem. The CLIA supplied an insulin concentra-
tion of 7.8 μIU/mL, whereupon this horse is classified
as insulin-sensitive when considering the cut-off value
of 20 μIU/mL recommended by the American College
of Veterinary Internal Medicine. By contrast, ELISA
and RIA supplied insulin concentrations of 50.73 μIU/mL
and 46.53 μIU/mL, respectively, after which this horse is
classified as insulin-resistant or insulin-dysregulated on
the basis of basal, fasted blood analysis. Both commercial
laboratories we commissioned with the analyses of our
samples provided laboratory-specific reference values for
insulin in fasted serum blood samples of horses. The refer-
ence range stated for the RIA was < 20 μIU/mL in fasted
samples and was < 23.4 μIU/mL for the CLIA. These find-
ings indicate that even consideration of laboratory and
assay-specific reference ranges leads to different classifica-
tion of this horse, depending on the assay used to deter-
mine the basal, fasted blood insulin concentration. As a
consequence, independent of laboratory and assay-specific
reference ranges or cut-off values, a general harmonization
of equine insulin analyses is urgently required to allow ac-
curate and safe diagnosis of hyperinsulinemia as one of the
leading symptoms in horses suffering from EMS.
Conclusion
In conclusion, analyses of equine serum samples for insu-
lin with three different immunoassay methods revealed
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three different results for the same sample. Adjustment
of insulin measurements and methods is essential to
allow the consistence of information of several studies
and research approaches, enabling evidence-based cri-
teria to compare insulin concentrations consistently be-
tween assays, studies and laboratories. Since harmonization
is an interminable process, further assay comparison re-
search studies would be helpful to allow the compari-
son of results and cut-off values determined with the
use of one method to another. This study illustrates the
importance of considering the insulin analysis method
when results of different laboratories or studies are
compared or interpreted for the diagnosis of insulin-
related endocrine and metabolic pathologies.
Endnotes
1Equine Insulin ELISA, Mercodia AB, Uppsala, Sweden.
2Porcine Insulin RIA, Millipore, St. Charles, MO,
USA.
3ADVIA Centaur Insulin Assay, Siemens Healthcare
Diagnostics GmbH, Eschborn, Germany.
4Vacuette® Greiner Bio One, Frickenhausen, Germany.
5Animal Insulin Control, 362 Mercodia AB, Uppsala,
Sweden.
6Diabetes Sample Buffer, Mercodia AB, Uppsala, Sweden.
7GraphPad Prism, Version 6.02 for Windows, Graph-
Pad Inc. La Jolla, CA, USA.
8Coat-a-Count Insulin RIA, Siemens Medical Solutions
Diagnostics, Los Angeles, CA, USA.
9Immulite Insulin Assay, Siemens Healthcare, Malvern,
PA, USA.
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